UBS downgraded Evercore from Buy to Neutral and set a new price target of $176.00 from $160.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/8/2025 | $230.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
| 4/7/2025 | $306.00 → $173.00 | Overweight → Equal-Weight | Morgan Stanley |
| 12/20/2024 | $269.00 → $339.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 9/12/2024 | $258.00 | Equal Weight | Wells Fargo |
| 9/11/2024 | $246.00 → $276.00 | Neutral → Buy | Goldman |
| 1/29/2024 | Mkt Perform | Keefe Bruyette | |
| 1/9/2024 | $160.00 → $176.00 | Buy → Neutral | UBS |
| 8/22/2023 | $158.00 → $140.00 | Buy → Neutral | Goldman |
Evercore (NYSE:EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U.S. Investment Banking, said, "It is a pleasure to welcome Joe to our team. Joe's deep connections in biopharma complement our existing relationships and will help further build on our leading track-record in the sector." "Having worked alongside Joe on numerous deals, I'm excited to welcome him to join our distinguished group of senior leaders in healthcare, where he will undoubtedly make a meaningful impact," added Francois Maisonrouge, chairman of Evercore's Global Healthcare Group. "The ph
Evercore (NYSE:EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business, based in New York. "We are excited to welcome David to Evercore," said Jason Sobol, co-head of Evercore's U.S. Investment Banking business. "David's best-in-class M&A execution excellence and exceptional relationships within the sponsor community make him a trusted advisor to so many. His insights will further our M&A expertise across industries, and by working alongside our existing financial sponsor group, he will complement our coverage effort as we continue to invest in and strengthen our platform to deliver outstanding r
Evercore Wealth Management today announced the appointment of Jonathan Kropf as partner and head of the San Francisco office. He is also named a managing director at Evercore Trust Company NA. Mr. Kropf joined Evercore in January 2025 from IEQ Capital, where he worked with advisor teams focused on business growth. Previously, he held a similar role as an executive at First Republic Private Wealth Management. He began his career at the U.S. Securities and Exchange Commission in Washington, D.C. Mr. Kropf has additionally worked as a management consultant at PwC, advising asset managers and the U.S. Department of Treasury. Mr. Kropf succeeds Keith McWilliams in leading the Evercore Wealth
4 - Evercore Inc. (0001360901) (Issuer)
4 - Evercore Inc. (0001360901) (Issuer)
4 - Evercore Inc. (0001360901) (Issuer)
Citizens JMP upgraded Evercore from Mkt Perform to Mkt Outperform and set a new price target of $230.00
Morgan Stanley downgraded Evercore from Overweight to Equal-Weight and set a new price target of $173.00 from $306.00 previously
Keefe Bruyette upgraded Evercore from Mkt Perform to Outperform and set a new price target of $339.00 from $269.00 previously
SC 13G/A - Evercore Inc. (0001360901) (Subject)
SC 13G/A - Evercore Inc. (0001360901) (Subject)
SC 13G/A - Evercore Inc. (0001360901) (Subject)
144 - Evercore Inc. (0001360901) (Subject)
144 - Evercore Inc. (0001360901) (Subject)
144 - Evercore Inc. (0001360901) (Subject)
Evercore (NYSE:EVR) will release its first quarter 2025 financial results on Wednesday, April 30, 2025 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's first quarter 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 225-9448 (toll-free domestic) or (203) 518-970
Evercore Inc. (NYSE:EVR): Fourth Quarter Results Full Year Results U.S. GAAP Adjusted U.S. GAAP Adjusted Q4 2024 Q4 2023 Q4 2024 Q4 2023 2024 2023 2024 2023 Net Revenues ($ mm) $ 975.3 $ 784.2 $ 980.5 $ 790.3 $ 2,979.6 $ 2,425.9 $ 3,002.6 $ 2,449.3 Operating Income ($ mm)
Evercore (NYSE:EVR) will release its fourth quarter and full year 2024 financial results on Wednesday, February 5, 2025 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's fourth quarter and full year 2024 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 445-7795 (to
Evercore (NYSE:EVR) will release its first quarter 2025 financial results on Wednesday, April 30, 2025 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's first quarter 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 225-9448 (toll-free domestic) or (203) 518-970
Evercore Wealth Management today announced the promotions of Paulo Coelho, Neza Gallitano and Alex Lyden to partner. Mr. Coelho and Ms. Gallitano are wealth & fiduciary advisors at Evercore Wealth Management and its affiliate, Evercore Trust Company N.A.; Mr. Lyden is the chief fiduciary officer at Evercore Trust Company. "Paulo, Neza and Alex are strong contributors to our firm, focused on meeting clients' financial goals and earning their trust," said Chris Zander, CEO of Evercore Wealth Management and Evercore Trust Company. "I am pleased to recognize their success and look forward to working with them as they continue to develop as leaders in our business." Mr. Coelho works with fam
Evercore (NYSE:EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U.S. Investment Banking, said, "It is a pleasure to welcome Joe to our team. Joe's deep connections in biopharma complement our existing relationships and will help further build on our leading track-record in the sector." "Having worked alongside Joe on numerous deals, I'm excited to welcome him to join our distinguished group of senior leaders in healthcare, where he will undoubtedly make a meaningful impact," added Francois Maisonrouge, chairman of Evercore's Global Healthcare Group. "The ph